Taldefgrobep and the SMN protein upregulator SMN-C1 were evaluated as a combined therapeutic approach in two different preclinical studies of murine SMA models using SMNΔ7 mice. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.